Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke | Zendy

Philip M. Bath | Zendy; Otto W. Witte | Zendy; Reneé H. Martin | Zendy; Yuko Y. Palesch | Zendy; Salim Yusuf | Zendy; Ralph L. Sacco | Zendy; HansChristoph Diener | Zendy; Conrado J. Estol | Zendy; Robin Roberts | Zendy

Open Access

Effect of Combined Aspirin and Extended-Release Dipyridamole Versus Clopidogrel on Functional Outcome and Recurrence in Acute, Mild Ischemic Stroke

Author(s) -

Philip M. Bath,

Otto W. Witte,

Reneé H. Martin,

Yuko Y. Palesch,

Salim Yusuf,

Ralph L. Sacco,

HansChristoph Diener,

Conrado J. Estol,

Robin Roberts

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.109.564906

Subject(s) - medicine , dipyridamole , clopidogrel , aspirin , stroke (engine) , cardiology , ischemic stroke , ticlopidine , platelet aggregation inhibitor , anesthesia , ischemia , mechanical engineering , engineering

Long-term antiplatelet therapy is effective at reducing recurrence after ischemic stroke. However, the relative safety and efficacy of combined aspirin-dipyridamole or clopidogrel are not known in patients with acute ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research